PIII icon

P3 Health Partners

0.2082 USD
-0.0099
4.54%
At close Feb 21, 4:00 PM EST
After hours
0.2099
+0.0017
0.82%
1 day
-4.54%
5 days
-13.25%
1 month
5.20%
3 months
-3.16%
6 months
-60.26%
Year to date
-16.72%
1 year
-80.17%
5 years
-98.07%
10 years
-98.07%
 

About: P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Employees: 400

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

7.64% less ownership

Funds ownership: 19.83% [Q3] → 12.19% (-7.64%) [Q4]

17% less funds holding

Funds holding: 46 [Q3] → 38 (-8) [Q4]

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

64% less capital invested

Capital invested by funds: $12.4M [Q3] → $4.49M (-$7.9M) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for PIII.

Financial journalist opinion

Based on 3 articles about PIII published over the past 30 days

Neutral
Business Wire
2 days ago
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts. Management is scheduled to host investor meetings on Wednesday March 5th, 2025. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transfor.
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
Neutral
Business Wire
1 week ago
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million. “The execution of our previously announced $130+ million EBITDA growth initiatives is going as planned, most of which have been actioned and implemented.
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
Neutral
GlobeNewsWire
1 week ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
Neutral
Business Wire
1 month ago
P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California. Management will give a presentation on Tuesday, January 14, 2024, at 7:30 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay wi.
P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Neutral
PRNewsWire
2 months ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
NEW YORK , Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
Neutral
Business Wire
2 months ago
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time. A live webcast of the presentation will be available the following day on P3's Investor Relations Website: https://ir.p3.
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
Neutral
Business Wire
3 months ago
P3 Health Partners to Participate in Upcoming Investor Conferences
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company will participate in the following upcoming investor conferences: - The 3rd Annual Needham Virtual Healthcare IT 1x1 Conference on Wednesday, November 20, 2024 - The BTIG Digital Health Forum on Monday, November 25, 2024 About P3 Health Partners (NASDAQ: PIII) P3 Health Partners Inc. is a leading p.
P3 Health Partners to Participate in Upcoming Investor Conferences
Neutral
Seeking Alpha
3 months ago
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Leif Pedersen - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Jack Senft - William Blair Operator Good day, and welcome to P3 Health Partners Third Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
P3 Health Partners Inc. (PIII) Reports Q3 Loss, Misses Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
P3 Health Partners Inc. (PIII) Reports Q3 Loss, Misses Revenue Estimates
Neutral
Business Wire
3 months ago
P3 Health Partners Announces Third Quarter 2024 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024. “As we execute on our strategic initiatives, we believe P3 will be well-positioned to unlock the value built within our platform and generate sustainable, profitable growth in the medium and long term,” said Aric Coffman, CEO of P3. “We hav.
P3 Health Partners Announces Third Quarter 2024 Results
Charts implemented using Lightweight Charts™